Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated

Joong Kyong Ahn1, Ji-Won Hwang, Jaejoon Lee

  • 1Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 108 Pyoung-Dong, Jongro-Ku, Seoul, Republic of Korea.

Rheumatology International
|September 8, 2011
PubMed

Insights

This study analyzed microscopic polyangiitis (MPA) using a new consensus algorithm, finding higher survival rates than previously reported. Interstitial lung disease emerged as a new risk factor for mortality in MPA patients.

Area of Science:

  • Rheumatology
  • Nephrology
  • Immunology

Background:

  • The classification of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis and polyarteritis nodosa faced challenges due to overlapping clinical features.
  • A new consensus algorithm was proposed to better differentiate these conditions.

Purpose of the Study:

  • To investigate the clinical features and outcomes of patients diagnosed with microscopic polyangiitis (MPA) using the newly proposed consensus algorithm.
  • To identify risk factors for mortality in MPA patients.

Main Methods:

  • Retrospective analysis of 55 MPA cases diagnosed via the new consensus algorithm at a tertiary hospital.
  • Evaluation of clinical manifestations, serological markers (P-ANCA, anti-MPO), and disease activity scores (Five Factor Score, BVAS).
  • Long-term follow-up of 44 patients to assess survival rates and identify mortality predictors.

Main Results:

  • Common clinical features included constitutional symptoms (78.2%), renal (74.5%), and musculoskeletal (67.3%) involvement.
  • P-ANCA and/or anti-MPO antibodies were detected in 69.1% of patients.
  • The 1- and 3-year survival rates were 93.9% and 89.2%, respectively, with mortality linked to BVAS > 9, age > 60, cardiomyopathy, and interstitial lung disease.

Conclusions:

  • The new consensus algorithm aids in diagnosing MPA, revealing distinct clinical features and improved survival rates compared to prior reports.
  • Interstitial lung disease is identified as a novel risk factor for mortality in MPA.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...